Juvenile rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 28, Issue 3, 2002, Pages 503-530

  Schneider, Rayfel ^a   Passo, Murray H ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036697243     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(02)00016-9     Document Type: Review

References (165)

1. Petty RE. Classification of childhood arthritis: a work in progress. Baillieres Clin Rheumatol 1998a;12(2):181-90.
2. Brewer EJ, Bass JC, Cassidy TJ, et al. Criteria for the classification of juvenile rheumatoid arthritis. Bull Rheum Dis 1973;23:712-9.
3. Brewer Jr. EJ, Bass JC, Baum J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum, 1977;20(Suppl 2):195-9.
4. Wood PH. Nomenclature and classification of arthritis in children. In: Munthe E, editor. The care of rheumatic children. Basel (Switzerland): European League Against Rheumatism; 1978. p. 47-50.
5. Fink CW. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995;22(8):1566-9.
6. Petty RE, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998b;25(10):1991-4.
7. Berntson L, et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. J Rheumatol 2001; 28(12):2737-43.
8. Ramsey SE, et al. Comparison of criteria for the classification of childhood arthritis. J Rheumatol 2000;27(5):1283-6.
9. Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 2000;27(4):1069-72.
10. Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001;28(5):1083-90.
11. Merino R, De Inocencio J, Garcia-Consuegra J. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children. J Rheumatol 2001;28(12):2731-6.
12. Fantini F. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. J Rheumatol 2001;28(2):456-9.
13. Petty RE. Growing pains: the ILAR classification of juvenile idiopathic arthritis. J Rheumatol 2001;28(5):927-8.
14. Thomas E. Barrett JH, Donn RP, Thomson W, Southwood TR, and the British Paediatric Rheumatology Group, Subtyping of juvenile idiopathic arthritis using latent class analysis. Arthritis Rheum 2000;43(7):1496-503.
15. Hochberg MC. The epidemiology of juvenile rheumatoid arthritis: Review of current status and approaches for future research. In: Lawrence RC, editor. Current Topics in Rheumatology: Epidemiology of the Rheumatic Diseases. New York: Gower Medical Publishing Ltd.; 1984. p. 220-30.
16. Gare BA. Juvenile arthritis - who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 1999;17(3):367-74.
17. Oen KG, Cheang M. Epidemiology of chronic arthritis in childhood. Semin Arthritis Rheum 1996;26(3):575-91.
18. Lawrence RC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41(5):778-99.
19. Manners PJ, Diepeveen DA. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics 1996;98(1):84-90.
20. Oen K. Comparative epidemiology of the rheumatic diseases in children. Curr Opin Rheumatol 2000;12(5):410-4.
21. Schwartz MM, et al. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997;24 (9):1826-9.
22. Pugh MT, Southwood TR, Gaston JS. The role of infection in juvenile chronic arthritis. Br J Rheumatol 1993;32(9):838-44.
23. Lindsley CB. Seasonal variation in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1987;30:838-9.
24. Feldman BM, Birdi N, Boone JE, Dent PB, et al. Seasonal onset of systemic-onset juvenile rheumatoid arthritis. J Pediatr 1996;129(4):513-8.
25. Uziel Y, et al. Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. J Rheumatol 1999;26(5):1187-9.
26. Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997;77(6):530-4.
27. Fernandez-Vina MA, Fink CW, Stastny P. HLA antigens in juvenile arthritis. Pauciarticular and polyarticular juvenile arthritis are immunogenetically distinct. Arthritis Rheum 1990;33(12): 1787-94.
28. Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999;42(11):2261-8.
29. Albert ED, Scholz S. Juvenile arthritis: genetic update. Baillieres Clin Rheumatol 1998;12(2): 209-18.
30. Moroldo MB, et al. Juvenile rheumatoid arthritis in affected sibpairs. Arthritis Rheum 1997;40 (11):1962-6.
31. Prahalad S, et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. Arthritis Rheum 2000;43(10):2335-8.
32. Murray KJ, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999;42(9):1843-53.
33. Haas JP, Berman SJ, Laurent MR, et al. Subtypes of HLA-DRB1 *03, *08, *11, *12, *13, and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin Exp Rheum 1994;12(Suppl 10):7-14.
34. Haas JP, et al. Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol 1994;41(3):225-33.
35. Pratsidou-Gertsi P, et al. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece. Eur J Immunogenet 1999;26 (4):299-310.
36. Date Y, et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5′-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum 1999;42(12): 2577-82.
37. Fishman D, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102(7):1369-76.
38. McDowell TL, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995;38(2):221-8.
39. Sanjeevi CB, et al. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum 2000;43(6):1397-404.
40. Donn RP, et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group. Arthritis Rheum 2001;44(4):802-10.
41. Ansell BM. Joint manifestations in children with juvenile chronic polyarthritis. Arthritis Rheum 1977;20(Suppl 2):204-6.
42. Cassidy JT, Brody GL, Martel W. Monoarticular juvenile rheumatoid arthritis. J Pediatr 1967; 70(6):867-75.
43. Al-Matar MJ, Cabral DA, Petty RE. Isolated tuberculous monoarthritis mimicking oligoarticular juvenile rheumatoid arthritis. J Rheumatol 2001;28(1):204-6.
44. Cohen M. Gonococcal arthritis. Bull Rheum Dis 1998;47(1):4-6.
45. North AFJ, et al. Sarcoid arthritis in children. Am J Med 1970;48(4):449-55.
46. Lindsley CB, Petty RE. Overview and report on international registry of sarcoid arthritis in childhood. Current Rheum Report 2000;2:343-8.
47. Lindsley CB, Godfrey WA. Childhood sarcoidosis manifesting as juvenile rheumatoid arthritis. Pediatrics 1985;76(5):765-8.
48. Bahabri SA, et al. The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1. Arthritis Rheum 1998;41(4):730-5.
49. Cabral DA, Tucker L. Malignancies in children who initially present with rheumatic complaints. J Peds 1999;134:53-7.
50. Trapani S, et al. Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum 2000;29(6): 348-59.
51. Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001;19:103-6.
52. Parez N, et al. Paediatric Castleman disease; report of seven cases and review of the literature. Eur J Pediatr 1999;158(8):631-7.
53. Majeed HA. Differential diagnosis of fever of unknown origin in children. Curr Opin Rheumatol 2000;12(5):439-44.
54. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001;345(24):1748-57.
55. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am 1991;17(4):891-905.
56. Flato B, et al. Measuring disability in early juvenile rheumatoid arthritis: evaluation of a Norwegian version of the childhood Health Assessment Questionnaire. J Rheumatol 1998;25 (9):1851-8.
57. Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford) 2000;39(2):198-204.
58. Lomater C, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000;27(2):491-6.
59. Guillaume S, et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000;43(8):1858-65.
60. Laaksonen AL. A prognostic study of juvenile rheumatoid arthritis. Analysis of 544 cases. Acta Paediatr Scand 1966;(Suppl 166):1-163.
61. Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol 1992;33:6-10.
62. Singh G, et al. Measurement of health status in children with juvenile rheumatoid arthritis. Arthitis Rheum 1994;37(12):1761-9.
63. Ruperto N, et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 1997;24(5):945-51.
64. Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome. J Rheumatol 1995;22(2):308-19.
65. Duffy CM, Tucker L, Burgos-Vargas R. Update on functional assessment tools. J Rheumatol 2000;27(Suppl 58):11-4.
66. Peterson LS, et al. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthitis Rheum 1997;40(12): 2235-40.
67. David J, et al. The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol 1994;33(9):876-81.
68. Mille JJ III, et al. The social function of young adults who had arthritis in childhood. J Pediatr 1982;100(3):378-82.
69. Cassidy JT, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthitis Rheum 1986;29(2):274-81.
70. Hull RG. Outcome in juvenile arthritis. Br J Rheumatol 1988;27(Suppl 1):66-71.
71. Schneider R, et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr 1992;120(2 Pt 1):200-5.
72. Modesto C, et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol 2001;19(2):211-7.
73. Spiegel LR, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthitis Rheum 2000;43(11):2402-9.
74. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol 1990;34(4):253-67.
75. Cabral DA, et al. Visua prognosis in children with chronic anterior uveitis and arthritis. J Rheumatol 1994;21(12):2370-5.
76. Dana MR, et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997;104(2):236-44.
77. Yaney C, White P, Magilavy D, et al. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993;92(2):295-6.
78. Ansell BM, Wood PHN. Prognosis in juvenile chronic polyarthritis. Clin Rheum Dis 1976;2: 397-412.
79. Stoeber E. Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children. Eur J Pediatr 1981;135(3):225-8.
80. Savolainen HA, Isomaki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20(7):1201-3.
81. Reed MH, Wilmot DM. The radiology of juvenile rheumatoid arthritis. A review of the English language literature. J Rheumatol Suppl 1991;31:2-22.
82. Sherry DD, et al. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthitis Rheum 1999; 42(11):2330-4.
83. De Benedetti F, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-1. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99(4):643-50.
84. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am 1996;25:699-717.
85. Kimura A, et al. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. J Rheumatol 2000;27(8):2018-24.
86. Al-Mutair A, et al. Efficacy of recombinant human growth hormone in children with juvenile rheumatoid arthritis and growth failure. J Pediatr Endocrinol Metab 2000;13(7):899-905.
87. Touati G, et al. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 1998;83(2):403-9.
88. Cassidy JT. Osteopenia and osteoporosis in children. Clin Exp Rheumatol 1999;17(2):245-50.
89. Cassidy JT, et al. Bone mineral metabolism in children with juvenile rheumatoid arthritis. Pediatr Clin North Am 1995;42(5):1017-33.
90. McDonagh JE. Osteoporosis in juvenile idiopathic arthritis. Curr Opin Rheumatol 2001;13(5): 399-404.
91. Rabinovich CE. Bone mineral status in juvenile rheumatoid arthritis. J Rheumatol 2000;27 (Suppl 58):34-7.
92. Pepmueller PH, et al. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996;39(5):746-57.
93. Kotaniemi A, et al. Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand J Rheumatol 1999;28(1):19-26.
94. Henderson CJ, et al. Predictors of total body bone mineral density in non-corticosteroidtreated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40(11): 1967-75.
95. Henderson CJ, et al. Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum 2000;43(3):531-40.
96. Murray K, Boyle RJ, Woo-London P. Pathological fractures and osteoporosis in a cohort of 103 systemic onset juvenile idiopathic arthritis patients. Arthritis Rheum 2000;43(Suppl):S119.
97. Brik R, et al. Bone mineral density and turnover in children with systemic juvenile chronic arthritis. J Rheumatol 1998;25(5):990-2.
98. Zak M, et al. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthritis Rheum 1999;42(4):790-8.
99. Haugen M, et al. Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm. Arthritis Rheum 2000;43(7):1504-10.
100. Warady BD, et al. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol 1994;21(3):530-5.
101. Astrom E, Soderhall S. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr 1998;87(1):64-8.
102. Glorieux FH, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998;339(14):947-52.
103. Bianchi M, Cimaz R, Bardare M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Arthritis Rheum 2000;43(9): 1960-6.
104. Brumsen C, Hamdy NAT, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton: Studies of young patients with severe osteoporosis. Medicine (Baltimore) 1997; 76(4):226-83.
105. Stephan JL, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40(11):1285-92.
106. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997;130(3):352-7.
107. Silverman ED, et al. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983;103(6):872-6.
108. Ravelli A, et al. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2001;28(4):865-7.
109. Wulffraat NM, Kuis W. Treatment of refractory juvenile idiopathic arthritis. J Rheumatol 2001; 28(5):929-31.
110. Ravelli A, et al. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996;128(2):275-8.
111. Mouy R, et al. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129(5):750-4.
112. Fishman D, Rooney M, Woo P. Successful management of reactive haemophagocytic syndrome in systemic-onset juvenile chronic arthritis. Br J Rheumatol 1995;34(9):888.
113. Prahalad S, et al. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 2001;28(9):2120-4.
114. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002;109(1):109-15.
115. Bloom BJ. New drug therapies for the pediatric rheumatic diseases. Curr Opin Rheumatol 2001;13(5):410-4.
116. Kulas DT, Schanberg L. Juvenile idiopathic arthritis. Curr Opin Rheumatol 2001;13(5): 392-8.
117. Dent PB, Walker N. Intra-articular corticosteroids in the treatment of juvenile rheumatoid arthritis. Curr Opin Rheumatol 1998;10(5):475-80.
118. Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998;41(7):1210-4.
119. Huppertz HI, et al. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 1995;127(2):317-21.
120. Giannini EH, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 1992;326(16):1043-9.
121. Wallace CA, Sherry DD. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheumatol 1992;19(10):1604-7.
122. Halle F, Prieur AM. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Clin Exp Rheumatol 1991;9(3):297-302.
123. Ravelli A, et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr 1999;135(3):316-20.
124. Woo P, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43(8): 1849-57.
125. Ravelli A, et al. Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. J Pediatr 1998;133(2):262-5.
126. Harel L, et al. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis Rheum 1993;36(10):1370-4.
127. Hashkes PJ, et al. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40(12):2226-34.
128. Hashkes PJ, et al. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1999;134(1):47-52.
129. Cron RQ, Sherry DD, Wallace CA. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 1998;132(5):901-2.
130. Londino AV Jr, Blatt J, Knisely AS. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate. J Rheumatol 1998;25(6):1245-6.
131. Padeh S, et al. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol 1997;24(10):2035-7.
132. Kamel OW, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328(18):1317-21.
133. Buckley LM, et al. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthitis Rheum 1997;40(5):971-3.
134. Morice AH, Lai WK. Fatal varicella zoster infection in a severe steroid dependent asthmatic patient receiving methotrexate. Thorax 1995;50(11):1221-2.
135. Gottlieb BS, et al. Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Pediatrics 1997;100(6):994-7.
136. van Rossum MA, et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum 1998;41(5):808-16.
137. Brooks CD. Sulfasalazine for the management of juvenile rheumatoid arthritis. J Rheumatol 2001;28(4):845-53.
138. Silverman E, Spiegel L, Hawkins D, et al. An initial evaluation of the efficacy and safety of leflunomide (LEF) in children with polyarticular course juvenile rheumatoid arthritis (JRA). Arthritis Rheum 2001;44(9):S272.
139. Kvien TK, Hoyeraal HM, Sandstad B. Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 1986;13(1): 118-23.
140. Savolainen A, et al. Azathioprine in patients with juvenile chronic arthritis: a longterm followup study. J Rheumatol 1997;24(12):2444-50.
141. Lin YT, et al. Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis. J Formos Med Assoc 2000;99(4):330-5.
142. Groothoff JW, van Leeuwen EF. High dose intravenous gammaglobulin in chronic systemic juvenile arthritis. Br Med J 1988;296(6633):1362-3.
143. Uziel Y, et al. Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study. J Rheumatol 1996;23(5):910-8.
144. Silverman ED, et al. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 1994;21(12):2352-8.
145. Giannini EH, et al. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/Il study. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 1996;23(5):919-24.
146. Prieur AM. Intravenous immunoglobulins in Still's disease: still controversial, still unproven. J Rheumatol 1996;23(5):797-800.
147. Gerloni V, et al. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford) 2001;40 (8):907-13.
148. Reiff A, et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 1997;24 (12):2436-43.
149. Pistoia V, et al. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol 1993;11(2): 203-8.
150. Ostensen M, Hoyeraal HM, Kass E. Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. J Rheumatol 1988;15(10):1536-8.
151. Lovell DJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342(11):763-9.
152. Takei S, et al. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. J Rheumatol 2001;28(7):1677-80.
153. Schmeling H, et al. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Ann Rheum Dis 2001;60(4):410-2.
154. Gerloni V, Pontikaki I, Desiati F. Evaluation of disease activity, disability, and quality of life in patients with persistently active refractory juvenile chronic arthritis after one year treatment with monoclonal anti-tumor necrosis factor-a antibody (infliximab). Arthritis Rheum 2001;44 (9):S80.
155. Lahdenne P, Honkanen V. Infliximab versus etanercept in the treatment of severe juvenile chronic arthritis (JCA). Arthritis Rheum 2000;43:S381.
156. Shaikov AV, et al. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritispreliminary results of a longterm study. J Rheumatol 1992;19(4):612-6.
157. Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40(10):1852-5.
158. Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 1997;39(2):242-4.
159. Kaipiainen-Seppanen O, Savolainen A. Changes in the incidence of juvenile rheumatoid arthritis in Finland. Rheumatology (Oxford) 2001;40(8):928-32.
160. Moe N, Rygg M. Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study. Clin Exp Rheumatol 1998;16(1):99-101.
161. Ozen S, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998;25(12):2445-9.
162. Kiessling U, et al. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980-88. J Rheumatol 1998;25(9):1837-43.
163. von Koskull S, et al. Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study. Ann Rheum Dis 2001;60(10):940-5.
164. Arguedas O, et al. Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study. J Rheumatol 1998;25(9):1844-50.
165. Peterson LS, et al. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 1996;39(8):1385-90.